Attached files
Exhibit
32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO SECTION 906
OF
THE SARBANES-OXLEY ACT OF 2002
In
connection with the Form 10-Q of Worldwide Biotech & Pharmaceutical Company
(the “Company”) on Form 10-Q for the quarter ended June 30, 2010, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Peng Wang, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge and belief:
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
/s/ Peng
Wang
Peng
Wang
Chief
Financial Officer
August
13, 2010